Arizona State Retirement System Has $2.70 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Arizona State Retirement System increased its position in Encompass Health Co. (NYSE:EHC) by 0.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,204 shares of the company’s stock after purchasing an additional 212 shares during the quarter. Arizona State Retirement System’s holdings in Encompass Health were worth $2,697,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. State Street Corp grew its position in shares of Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after buying an additional 21,329 shares during the period. Geode Capital Management LLC grew its holdings in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after acquiring an additional 20,547 shares during the period. Copeland Capital Management LLC raised its position in shares of Encompass Health by 0.7% during the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after acquiring an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in shares of Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after purchasing an additional 835,135 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Encompass Health by 0.4% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock worth $71,083,000 after purchasing an additional 2,904 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.10% of the company’s stock.

Encompass Health Stock Down 0.5 %

Shares of EHC stock opened at $99.20 on Monday. Encompass Health Co. has a 12-month low of $74.27 and a 12-month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average of $96.95 and a 200-day moving average of $96.80. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 22.24, a P/E/G ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities research analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on EHC. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Barclays lifted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, KeyCorp lifted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.